Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
T. O'Donnell, E. L. Christie, A. Ahuja, J. Buros, B. A. Aksoy, D. D. L. Bowtell, A. Snyder, J. Hammerbacher
This study examines how chemotherapy affects neoantigen expression in ovarian cancer by analyzing mutational signatures and neoantigen burden in pre- and post-treatment samples.
BMC Cancer · Jan 22, 2018Peer-reviewedCancer Biology